Overview
Indications
ESTRING is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.
Contraindications
When this intervention should not be used
ESTRING is contraindicated in women with any of the following conditions: 1 Abnormal genital bleeding with unknown etiology. 2 Known or suspected estrogen-dependent neoplasia. 3 Active DVT, PE, or a history of these conditions. 4 Active arterial thromboembolic disease (for example, stroke and MI), o
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
78 trials linked to this intervention
Recent Trials
TRADE-Testosterone Replacement and Dutasteride Effectiveness
Study Evaluating Totelle® in Menopausal Symptoms and Sexual Function
Efficacy and Safety Study in Postmenopausal Women to Determine the Lowest Effective Dose for Relief of Moderate to Severe Hot-Flushes
Study of Paxil Use in Menopausal Women
Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Estradiol (substance)
- SNOMED CT
- 126172005
- UMLS CUI
- C0014912
- RxNorm CUI
- 4083
- Labeler
- Pfizer Laboratories Div Pfizer Inc
Clinical Data
This intervention maps to 13 entities in the Healos knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.